Related Experiment Video
Updated: Sep 14, 2025
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
Achieving Therapeutic Success with Spesolimab: Two Cases of Drug-Induced Generalized Pustular Psoriasis Initially
Jianxia Chen1, Yuting Xia2,3, Faqiong Zhou1
1Department of Dermatology, The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Enshi, Hubei, People's Republic of China.
Background:
Patients with newly diagnosed generalized pustular psoriasis (GPP) lacking a history of psoriasis but with recent medication exposure may present with clinical features overlapping with acute generalized exanthematous pustulosis (AGEP). Accurate differentiation is critical for treatment and prognosis.
Case Summary:
We report two cases of drug-induced GPP initially with AGEP-like manifestations. Both patients received systemic glucocorticoids and cyclosporine yet exhibited recurrent pustular flares with lakes of pus and a prolonged disease course exceeding two months. Genetic testing confirmed IL36RN mutations in both cases. Subsequent spesolimab therapy achieved rapid resolution of pustules and sustained remission.
Conclusion:
In patients with first-onset drug-induced pustulosis resembling AGEP, the presence of lakes of pus, prolonged duration, and recurrent flares despite conventional therapies should be diagnosed as GPP promptly. Early intervention with spesolimab demonstrates efficacy in controlling disease activity and improving outcomes.
More Related Videos
06:13Enzyme-linked Immunospot Assay ELISPOT: Quantification of Th-1 Cellular Immune Responses Against Microbial Antigens
Published on: November 23, 2010
06:37Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety
Published on: September 15, 2023
